Table 1 Baseline clinical characteristics of the patients with and without new coronary events (NCE) in one year of follow up.
| Variable | NCE− (n = 57) | NCE+ (n = 23) | p Value |
|---|---|---|---|
| Age (years) | 63 (11) | 60 (10) | NS |
| Men/women | 43/14 | 17/6 | NS |
| Hypertension | 41 (71%) | 16 (69%) | NS |
| Dyslipidaemia | 31 (54%) | 14 (61%) | NS |
| Diabetes | 11 (19%) | 4 (17%) | NS |
| Previous MI | 11 (19%) | 5 (21%) | NS |
| Previous PCI | 5 (8.8%) | 0 | NS |
| Previous CABG | 7 (12%) | 3 (13%) | NS |
| Atrial fibrillation | 0 (%0) | 3 (%13) | 0.01 |
| CK‐MB (ng/ml) | 17 (30) | 9.4 (15) | NS |
| Myoglobin (ng/ml) | 196 (174) | 119 (98) | NS |
| Troponin (ng/ml) | 2.3 (7.9) | 0.7 (1.4) | NS |
| Ejection fraction (%)* | 55 (11) | 51 (12) | NS |
| Prior drug treatment | |||
| Statin | 45 (78%) | 21 (91%) | NS |
| Aspirin | 32 (56%) | 14 (61%) | NS |
| ACE inhibitor | 11 (19%) | 3 (13%) | NS |
| β blocker | 15 (26%) | 4 (17%) | NS |
| TIMI score | NS | ||
| 3 | 25 (44%) | 6 (26%) | |
| 4 | 14 (24%) | 8 (34%) | |
| 5 | 12 (21%) | 8 (35%) | |
| 6 | 6 (10.5%) | 1 (4%) |
*Determined by the modified Simpson's method with transthoracic echocardiography.
Data are mean (SD) or number (%).
ACE, angiotensin‐converting enzyme; CABG, coronary artery bypass grafting; CK, creatine kinase; MI, myocardial infarction; PCI, percutaneous coronary intervention; TIMI, Thrombolysis In Myocardial Infarction.